Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study

2021

Al-Sawaf, Othman

Zhang, Can

Lu, Tong

Liao, Michael Z.

Panchal, Anesh

et al.

Wissenschaftlicher Artikel

Journal of Clinical Oncology ; 39 (2021), 36. - S. 4049-4060. - ISSN 0732-183X. - eISSN 1527-7755

UKU. Klinik für Innere Medizin III

[Free subject headings]: CHRONIC LYMPHOCYTIC-LEUKEMIA | QUANTIFICATION | CHLORAMBUCIL | GUIDELINES
[DDC subject group]: DDC 610 / Medicine & health